Assessment of the Temporal Trajectory of Clinical Trials for COVID-19 Interventions After Highly Publicized Lay and Medical Attention.
Identifieur interne : 000281 ( Main/Corpus ); précédent : 000280; suivant : 000282Assessment of the Temporal Trajectory of Clinical Trials for COVID-19 Interventions After Highly Publicized Lay and Medical Attention.
Auteurs : Nadir YehyaSource :
- JAMA network open [ 2574-3805 ] ; 2021.
English descriptors
- KwdEn :
- Adrenal Cortex Hormones (therapeutic use), Ascorbic Acid (therapeutic use), COVID-19 (drug therapy), Clinical Trials as Topic (MeSH), Communication (MeSH), Decision Making (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Judgment (MeSH), Mass Media (MeSH), Persuasive Communication (MeSH), SARS-CoV-2 (MeSH), Sepsis (drug therapy), Social Media (MeSH).
- MESH :
- chemical , therapeutic use : Adrenal Cortex Hormones, Ascorbic Acid, Hydroxychloroquine.
- drug therapy : COVID-19, Sepsis.
- Clinical Trials as Topic, Communication, Decision Making, Humans, Judgment, Mass Media, Persuasive Communication, SARS-CoV-2, Social Media.
DOI: 10.1001/jamanetworkopen.2021.0689
PubMed: 33662130
PubMed Central: PMC7933998
Links to Exploration step
pubmed:33662130Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessment of the Temporal Trajectory of Clinical Trials for COVID-19 Interventions After Highly Publicized Lay and Medical Attention.</title>
<author><name sortKey="Yehya, Nadir" sort="Yehya, Nadir" uniqKey="Yehya N" first="Nadir" last="Yehya">Nadir Yehya</name>
<affiliation><nlm:affiliation>Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33662130</idno>
<idno type="pmid">33662130</idno>
<idno type="doi">10.1001/jamanetworkopen.2021.0689</idno>
<idno type="pmc">PMC7933998</idno>
<idno type="wicri:Area/Main/Corpus">000281</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000281</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Assessment of the Temporal Trajectory of Clinical Trials for COVID-19 Interventions After Highly Publicized Lay and Medical Attention.</title>
<author><name sortKey="Yehya, Nadir" sort="Yehya, Nadir" uniqKey="Yehya N" first="Nadir" last="Yehya">Nadir Yehya</name>
<affiliation><nlm:affiliation>Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">JAMA network open</title>
<idno type="eISSN">2574-3805</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Cortex Hormones (therapeutic use)</term>
<term>Ascorbic Acid (therapeutic use)</term>
<term>COVID-19 (drug therapy)</term>
<term>Clinical Trials as Topic (MeSH)</term>
<term>Communication (MeSH)</term>
<term>Decision Making (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Judgment (MeSH)</term>
<term>Mass Media (MeSH)</term>
<term>Persuasive Communication (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Sepsis (drug therapy)</term>
<term>Social Media (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term>
<term>Ascorbic Acid</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
<term>Sepsis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Communication</term>
<term>Decision Making</term>
<term>Humans</term>
<term>Judgment</term>
<term>Mass Media</term>
<term>Persuasive Communication</term>
<term>SARS-CoV-2</term>
<term>Social Media</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33662130</PMID>
<DateCompleted><Year>2021</Year>
<Month>03</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>03</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>4</Volume>
<Issue>3</Issue>
<PubDate><Year>2021</Year>
<Month>03</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>JAMA network open</Title>
<ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
</Journal>
<ArticleTitle>Assessment of the Temporal Trajectory of Clinical Trials for COVID-19 Interventions After Highly Publicized Lay and Medical Attention.</ArticleTitle>
<Pagination><MedlinePgn>e210689</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2021.0689</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yehya</LastName>
<ForeName>Nadir</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>K23 HL136688</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>L40 HL134039</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 HL148054</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2021</Year>
<Month>03</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>JAMA Netw Open</MedlineTA>
<NlmUniqueID>101729235</NlmUniqueID>
<ISSNLinking>2574-3805</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber>
<NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003142" MajorTopicYN="Y">Communication</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003657" MajorTopicYN="Y">Decision Making</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007600" MajorTopicYN="N">Judgment</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008402" MajorTopicYN="N">Mass Media</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010565" MajorTopicYN="N">Persuasive Communication</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061108" MajorTopicYN="N">Social Media</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>17</Hour>
<Minute>15</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>3</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>3</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33662130</ArticleId>
<ArticleId IdType="pii">2776966</ArticleId>
<ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0689</ArticleId>
<ArticleId IdType="pmc">PMC7933998</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>N Engl J Med. 2021 Feb 25;384(8):693-704</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32678530</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Oct 20;173(8):623-631</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32673060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chest. 2017 Jun;151(6):1229-1238</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27940189</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2018 Mar 01;378(9):809-818</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29490185</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2019 Oct 1;322(13):1261-1270</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31573637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000281 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000281 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:33662130 |texte= Assessment of the Temporal Trajectory of Clinical Trials for COVID-19 Interventions After Highly Publicized Lay and Medical Attention. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33662130" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |